Surufatinib DDI With a PPI and a CYP3A Inducer
Clinical trial NCT04510649 · COMPLETED
Trial details
- NCT number
- NCT04510649
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2020-09-11
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.